Vivek Chilukuri and Hannah Kelley
The biorevolution is upon us. Converging breakthroughs in biological sequencing, engineering biology, and machine learning are ushering in an almost science fiction–like world in which humans can manipulate and even design the building blocks of life with increasing sophistication—for good or ill. In this world, cutting-edge biotechnologies will create organs, capture carbon emissions, restore polluted environments, tailor medicines to a person’s genes, and replace vulnerable supply chains for food, fuel, fabrics, and firepower with domestic biobased alternatives. According to one estimate, existing biotechnologies could have a direct economic impact of $4 trillion a year for the next 20 years.1 As innovation continues, the ceiling could be far higher.
If next-generation biotechnologies hold great promise, they also come with gathering perils from new bioweapons, intrusive biosurveillance, and the race for biotechnology breakthroughs without adequate safeguards for public health, the environment, and democratic values. For policymakers, the question is not whether the biorevolution has transformative power, but which nation will responsibly harness that power to unlock new tools for defense, health, manufacturing, food security, environmental remediation, and the fight against climate change. No country is better positioned to lead the biorevolution than the United States, but it requires that policymakers act now with swift, ambitious, and far-sighted steps to secure America’s place as the global biopower.
No comments:
Post a Comment